Calidi Biotherapeutics Inc’s filing revealed that its CEO and Chairman of the Board Camaisa Allan unloaded Company’s shares for reported $16200.0 on Dec 17 ’24. In the deal valued at $1.62 per share,10,000 shares were sold. As a result of this transaction, Camaisa Allan now holds 66,712 shares worth roughly $98066.64.
H.C. Wainwright initiated its Calidi Biotherapeutics Inc [CLDI] rating to a Buy in a research note published on November 22, 2023; the price target was $11. A number of analysts have revised their coverage, including Robert W. Baird’s analysts, who began to cover the stock in early October with a ‘”an Outperform”‘ rating.
Price Performance Review of CLDI
On Tuesday, Calidi Biotherapeutics Inc [AMEX:CLDI] saw its stock jump 17.60% to $1.47. Over the last five days, the stock has gained 20.49%. Calidi Biotherapeutics Inc shares have risen nearly 27.83% since the year began. Nevertheless, the stocks have fallen -89.93% over the past one year. While a 52-week high of $16.80 was reached on 01/07/25, a 52-week low of $0.73 was recorded on 01/02/25. SMA at 50 days reached $1.7198, while 200 days put it at $1.9715.
Levels Of Support And Resistance For CLDI Stock
The 24-hour chart illustrates a support level at 1.3233, which if violated will result in even more drops to 1.1767. On the upside, there is a resistance level at 1.5533. A further resistance level may holdings at 1.6367. The Relative Strength Index (RSI) on the 14-day chart is 47.28, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0519, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 44.24%. Stochastics %K at 31.23% indicates the stock is a holding.
How much short interest is there in Calidi Biotherapeutics Inc?
A steep rise in short interest was recorded in Calidi Biotherapeutics Inc stocks on 2024-10-31, growing by 0.42 million shares to a total of 0.59 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 0.16 million shares. There was a rise of 72.5%, which implies that there is a positive sentiment for the stock.
